Mutations in the tumor-suppressor gene, TP53, which plays a crucial role in cell-cycle regulation, DNA repair, and apoptosis, are the most common mutations in human neoplasms and are associated with worse prognoses in patients with HCC who undergo liver transplantation [112]. This evidence concerns the gene TP53 and neoplasm.